Fang Ni
Director of Finance/CFO bij BLACK DIAMOND THERAPEUTICS, INC.
Vermogen: 635 722 $ op 31-03-2024
Profiel
Fang Ni is currently the Chief Financial & Business Officer at Black Diamond Therapeutics, Inc. Prior to this role, Dr. Ni worked as the Director-Global Business Development & Licensing at F.
Hoffmann-La Roche Ltd.
from 2013 to 2017.
From 2017 to 2020, Dr. Ni served as a Principal at Versant Ventures (Switzerland) GmbH.
Dr. Ni also held the position of Chief Business Officer at Monte Rosa Therapeutics AG and Bright Peak Therapeutics AG.
Dr. Ni obtained a doctorate degree from Purdue University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-02-2024 | 125 389 ( 0.24% ) | 635 722 $ | 31-03-2024 |
Actieve functies van Fang Ni
| Bedrijven | Functie | Begin |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Director of Finance/CFO | 19-11-2021 |
Eerdere bekende functies van Fang Ni
| Bedrijven | Functie | Einde |
|---|---|---|
| Versant Ventures (Switzerland) GmbH | Private Equity Analyst | 01-08-2020 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01-11-2017 |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Monte Rosa Therapeutics AG
 Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Monte Rosa Therapeutics AG develops, manufactures and distributes cancer drugs that modulate protein degradation pathways. The company was founded in 2018 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Opleiding van Fang Ni
| Purdue University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
| Versant Ventures (Switzerland) GmbH | Finance |
Monte Rosa Therapeutics AG
Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Monte Rosa Therapeutics AG develops, manufactures and distributes cancer drugs that modulate protein degradation pathways. The company was founded in 2018 and is headquartered in Basel, Switzerland. | Health Technology |
Bright Peak Therapeutics AG
Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Health Technology |
